Krystal Biotech, Inc. (BIT:1KRYS)
Italy · Delayed Price · Currency is EUR 138.65
0.00 (0.00%)
At close: Oct 6, 2025
Krystal Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | 146.73 | 89.16 | 10.93 | -139.98 | -69.57 | -32.17 | Upgrade |
Depreciation & Amortization | 6.26 | 6.71 | 5.91 | 3.39 | 2.77 | 1.85 | Upgrade |
Stock-Based Compensation | 54.27 | 49.13 | 39.93 | 33.23 | 15.32 | 3.27 | Upgrade |
Other Adjustments | -6.35 | -7.12 | -107.06 | 0.13 | 1.04 | 0.04 | Upgrade |
Change in Receivables | -8.2 | -62.71 | -42.04 | - | - | - | Upgrade |
Changes in Inventories | -10.71 | -11.91 | -4.48 | - | - | - | Upgrade |
Changes in Accounts Payable | 4.53 | 1.01 | -0.1 | -1.25 | 0.71 | 0.78 | Upgrade |
Changes in Accrued Expenses | 41.73 | 67.47 | 10.54 | 5.17 | 2.71 | 2.31 | Upgrade |
Changes in Other Operating Activities | 1.06 | -8.32 | -2.44 | -1.26 | -0.91 | -2.17 | Upgrade |
Operating Cash Flow | 195.4 | 123.42 | -88.8 | -100.57 | -47.94 | -26.08 | Upgrade |
Capital Expenditures | -9.96 | -4.24 | -11.8 | -52.98 | -68.34 | -14.84 | Upgrade |
Proceeds from Sale of Intangible Assets | - | - | 100 | - | - | - | Upgrade |
Purchases of Investments | -507.71 | -457.74 | -508.78 | -318.78 | -190.46 | -3.21 | Upgrade |
Proceeds from Sale of Investments | 333.83 | 298.54 | 503.21 | 257.68 | 32.03 | 6.87 | Upgrade |
Investing Cash Flow | -183.4 | -163.44 | 82.64 | -114.08 | -226.77 | -11.18 | Upgrade |
Long-Term Debt Repaid | - | - | - | - | -7.96 | - | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | - | - | - | -7.96 | - | Upgrade |
Issuance of Common Stock | 9.05 | 32.4 | 203.5 | 36 | 355.65 | 118.02 | Upgrade |
Repurchase of Common Stock | - | -5.39 | -0.75 | -0.65 | - | - | Upgrade |
Net Common Stock Issued (Repurchased) | 9.05 | 27.01 | 202.75 | 35.35 | 355.65 | 118.02 | Upgrade |
Financing Cash Flow | -4.88 | 27.01 | 202.75 | 35.35 | 347.69 | 118.02 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.92 | -0.46 | -0.16 | -0.04 | - | - | Upgrade |
Net Cash Flow | 8.04 | -13.46 | 196.43 | -179.35 | 72.98 | 80.76 | Upgrade |
Beginning Cash & Cash Equivalents | 345.79 | 358.33 | 161.9 | 341.25 | 268.27 | 187.51 | Upgrade |
Ending Cash & Cash Equivalents | 353.83 | 344.87 | 358.33 | 161.9 | 341.25 | 268.27 | Upgrade |
Free Cash Flow | 185.44 | 119.18 | -100.6 | -153.55 | -116.27 | -40.93 | Upgrade |
Free Cash Flow Growth | 55.60% | - | - | - | - | - | Upgrade |
FCF Margin | 51.63% | 41.02% | -198.43% | - | - | - | Upgrade |
Free Cash Flow Per Share | 6.20 | 4.01 | -3.63 | -6.02 | -5.24 | -2.18 | Upgrade |
Levered Free Cash Flow | 179.64 | 139.88 | 8.56 | -186.91 | -140.59 | -44.24 | Upgrade |
Unlevered Free Cash Flow | 164.9 | 112.15 | -95.38 | -192.13 | -131.34 | -45.07 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.